Prophylactic residual aneurysmal sac embolization with expandable hydrogel embolic devices for endoleak prevention: Preliminary study in dogs

Takao Hiraki, Dusan Pavcnik, Barry T. Uchida, Hans A. Timmermans, Qiang Yin, Reng Hong Wu, Mahtab Niyyati, Frederick S. Keller, Josef Rösch

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: To explore the feasibility and efficacy of residual aneurysmal sac (RAS) embolization with the expandable hydrogel embolic device (EHED) in prevention of endoleaks in a surgically created and endoluminally treated abdominal aortic aneurysm (AAA). Methods: In eight dogs, an AAA was created by means of side-to-side anastomosis between the infrarenal abdominal aorta and inferior vena cava (IVC) with ligation of the IVC above and below the anastomotic end, followed by deployment of an endograft with holes. The RAS was then embolized with the EHED. One animal was killed immediately after RAS embolization and one animal died 12 hr after the procedure. Follow-up aortograms were obtained in six animals after 1 day (1 animal), 2 weeks and 6 months (1 animal), and 8 weeks (4 animals). Results: Four animals had no endoleaks on the follow-up aortograms. The remaining two animals with incomplete RAS embolization had moderate type III endoleaks. Type I or II endoleaks were not seen in any animals. Complications included RAS wall penetration by the devices with platinum wires in two animals (nos. 1 and 2), device migration into an aortic circulation through the endograft holes in two animals (nos. 2 and 3) or through distal interstices between the aortic wall and endograft in one animal (no. 8), aortic occlusion in three animals (nos. 3, 7, and 8), and RAS rupture in one animal (no. 7). Histologic examination showed expanded hydrogels occupying the RAS with associated mature or immature organized thrombus, fibrinous thrombus, or degenerate blood cells. Conclusion: RAS embolization was feasible with the EHED, although additional modifications to the device are required to avoid complications. Angiographic and histologic results suggested that RAS embolization with the EHED may help in the prevention of endoleaks.

Original languageEnglish
Pages (from-to)459-466
Number of pages8
JournalCardioVascular and Interventional Radiology
Volume28
Issue number4
DOIs
Publication statusPublished - May 2005
Externally publishedYes

Fingerprint

Endoleak
Hydrogel
Dogs
Equipment and Supplies
Abdominal Aortic Aneurysm
Inferior Vena Cava
Thrombosis
Hydrogels
Abdominal Aorta
Platinum

Keywords

  • Aneurysm, aortic
  • Embolization
  • Endoleak

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Prophylactic residual aneurysmal sac embolization with expandable hydrogel embolic devices for endoleak prevention : Preliminary study in dogs. / Hiraki, Takao; Pavcnik, Dusan; Uchida, Barry T.; Timmermans, Hans A.; Yin, Qiang; Wu, Reng Hong; Niyyati, Mahtab; Keller, Frederick S.; Rösch, Josef.

In: CardioVascular and Interventional Radiology, Vol. 28, No. 4, 05.2005, p. 459-466.

Research output: Contribution to journalArticle

Hiraki, Takao ; Pavcnik, Dusan ; Uchida, Barry T. ; Timmermans, Hans A. ; Yin, Qiang ; Wu, Reng Hong ; Niyyati, Mahtab ; Keller, Frederick S. ; Rösch, Josef. / Prophylactic residual aneurysmal sac embolization with expandable hydrogel embolic devices for endoleak prevention : Preliminary study in dogs. In: CardioVascular and Interventional Radiology. 2005 ; Vol. 28, No. 4. pp. 459-466.
@article{9c702a7589414f0b9c56e48d2b7288d7,
title = "Prophylactic residual aneurysmal sac embolization with expandable hydrogel embolic devices for endoleak prevention: Preliminary study in dogs",
abstract = "Objective: To explore the feasibility and efficacy of residual aneurysmal sac (RAS) embolization with the expandable hydrogel embolic device (EHED) in prevention of endoleaks in a surgically created and endoluminally treated abdominal aortic aneurysm (AAA). Methods: In eight dogs, an AAA was created by means of side-to-side anastomosis between the infrarenal abdominal aorta and inferior vena cava (IVC) with ligation of the IVC above and below the anastomotic end, followed by deployment of an endograft with holes. The RAS was then embolized with the EHED. One animal was killed immediately after RAS embolization and one animal died 12 hr after the procedure. Follow-up aortograms were obtained in six animals after 1 day (1 animal), 2 weeks and 6 months (1 animal), and 8 weeks (4 animals). Results: Four animals had no endoleaks on the follow-up aortograms. The remaining two animals with incomplete RAS embolization had moderate type III endoleaks. Type I or II endoleaks were not seen in any animals. Complications included RAS wall penetration by the devices with platinum wires in two animals (nos. 1 and 2), device migration into an aortic circulation through the endograft holes in two animals (nos. 2 and 3) or through distal interstices between the aortic wall and endograft in one animal (no. 8), aortic occlusion in three animals (nos. 3, 7, and 8), and RAS rupture in one animal (no. 7). Histologic examination showed expanded hydrogels occupying the RAS with associated mature or immature organized thrombus, fibrinous thrombus, or degenerate blood cells. Conclusion: RAS embolization was feasible with the EHED, although additional modifications to the device are required to avoid complications. Angiographic and histologic results suggested that RAS embolization with the EHED may help in the prevention of endoleaks.",
keywords = "Aneurysm, aortic, Embolization, Endoleak",
author = "Takao Hiraki and Dusan Pavcnik and Uchida, {Barry T.} and Timmermans, {Hans A.} and Qiang Yin and Wu, {Reng Hong} and Mahtab Niyyati and Keller, {Frederick S.} and Josef R{\"o}sch",
year = "2005",
month = "5",
doi = "10.1007/s00270-004-4047-9",
language = "English",
volume = "28",
pages = "459--466",
journal = "CardioVascular and Interventional Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Prophylactic residual aneurysmal sac embolization with expandable hydrogel embolic devices for endoleak prevention

T2 - Preliminary study in dogs

AU - Hiraki, Takao

AU - Pavcnik, Dusan

AU - Uchida, Barry T.

AU - Timmermans, Hans A.

AU - Yin, Qiang

AU - Wu, Reng Hong

AU - Niyyati, Mahtab

AU - Keller, Frederick S.

AU - Rösch, Josef

PY - 2005/5

Y1 - 2005/5

N2 - Objective: To explore the feasibility and efficacy of residual aneurysmal sac (RAS) embolization with the expandable hydrogel embolic device (EHED) in prevention of endoleaks in a surgically created and endoluminally treated abdominal aortic aneurysm (AAA). Methods: In eight dogs, an AAA was created by means of side-to-side anastomosis between the infrarenal abdominal aorta and inferior vena cava (IVC) with ligation of the IVC above and below the anastomotic end, followed by deployment of an endograft with holes. The RAS was then embolized with the EHED. One animal was killed immediately after RAS embolization and one animal died 12 hr after the procedure. Follow-up aortograms were obtained in six animals after 1 day (1 animal), 2 weeks and 6 months (1 animal), and 8 weeks (4 animals). Results: Four animals had no endoleaks on the follow-up aortograms. The remaining two animals with incomplete RAS embolization had moderate type III endoleaks. Type I or II endoleaks were not seen in any animals. Complications included RAS wall penetration by the devices with platinum wires in two animals (nos. 1 and 2), device migration into an aortic circulation through the endograft holes in two animals (nos. 2 and 3) or through distal interstices between the aortic wall and endograft in one animal (no. 8), aortic occlusion in three animals (nos. 3, 7, and 8), and RAS rupture in one animal (no. 7). Histologic examination showed expanded hydrogels occupying the RAS with associated mature or immature organized thrombus, fibrinous thrombus, or degenerate blood cells. Conclusion: RAS embolization was feasible with the EHED, although additional modifications to the device are required to avoid complications. Angiographic and histologic results suggested that RAS embolization with the EHED may help in the prevention of endoleaks.

AB - Objective: To explore the feasibility and efficacy of residual aneurysmal sac (RAS) embolization with the expandable hydrogel embolic device (EHED) in prevention of endoleaks in a surgically created and endoluminally treated abdominal aortic aneurysm (AAA). Methods: In eight dogs, an AAA was created by means of side-to-side anastomosis between the infrarenal abdominal aorta and inferior vena cava (IVC) with ligation of the IVC above and below the anastomotic end, followed by deployment of an endograft with holes. The RAS was then embolized with the EHED. One animal was killed immediately after RAS embolization and one animal died 12 hr after the procedure. Follow-up aortograms were obtained in six animals after 1 day (1 animal), 2 weeks and 6 months (1 animal), and 8 weeks (4 animals). Results: Four animals had no endoleaks on the follow-up aortograms. The remaining two animals with incomplete RAS embolization had moderate type III endoleaks. Type I or II endoleaks were not seen in any animals. Complications included RAS wall penetration by the devices with platinum wires in two animals (nos. 1 and 2), device migration into an aortic circulation through the endograft holes in two animals (nos. 2 and 3) or through distal interstices between the aortic wall and endograft in one animal (no. 8), aortic occlusion in three animals (nos. 3, 7, and 8), and RAS rupture in one animal (no. 7). Histologic examination showed expanded hydrogels occupying the RAS with associated mature or immature organized thrombus, fibrinous thrombus, or degenerate blood cells. Conclusion: RAS embolization was feasible with the EHED, although additional modifications to the device are required to avoid complications. Angiographic and histologic results suggested that RAS embolization with the EHED may help in the prevention of endoleaks.

KW - Aneurysm, aortic

KW - Embolization

KW - Endoleak

UR - http://www.scopus.com/inward/record.url?scp=24044547361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24044547361&partnerID=8YFLogxK

U2 - 10.1007/s00270-004-4047-9

DO - 10.1007/s00270-004-4047-9

M3 - Article

C2 - 16001135

AN - SCOPUS:24044547361

VL - 28

SP - 459

EP - 466

JO - CardioVascular and Interventional Radiology

JF - CardioVascular and Interventional Radiology

SN - 7415-5101

IS - 4

ER -